S&P 500
(1.11%) 5 104.29 points
Dow Jones
(0.45%) 38 257 points
Nasdaq
(2.13%) 15 944 points
Oil
(0.11%) $83.66
Gas
(-1.16%) $1.619
Gold
(0.28%) $2 349.00
Silver
(-0.49%) $27.22
Platinum
(0.22%) $922.55
USD/EUR
(0.33%) $0.935
USD/NOK
(0.68%) $11.03
USD/GBP
(0.15%) $0.800
USD/RUB
(-0.32%) $91.88

Realtime updates for Pila Pharma AB (publ) [PILA.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated26 Apr 2024 @ 10:56

6.98% SEK 2.30

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 10:56):

PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2a clinical trials for type 2 diabetes...

Stats
Today's Volume 113 559
Average Volume 36 842.00
Market Cap 54.72M
EPS SEK0 ( 2024-02-27 )
Next earnings date ( SEK0 ) 2024-05-29
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -4.89
ATR14 SEK0.0730 (3.17%)

Pila Pharma AB (publ) Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pila Pharma AB (publ) Financials

Annual 2023
Revenue: SEK1.46M
Gross Profit: SEK-5.32M (-363.36 %)
EPS: SEK-0.470
FY 2023
Revenue: SEK1.46M
Gross Profit: SEK-5.32M (-363.36 %)
EPS: SEK-0.470
FY 2022
Revenue: SEK1.88M
Gross Profit: SEK-8.89M (-472.64 %)
EPS: SEK-2.59
FY 2021
Revenue: SEK719 230
Gross Profit: SEK680 939 (94.68 %)
EPS: SEK-0.548

Financial Reports:

No articles found.

Pila Pharma AB (publ)

PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2a clinical trials for type 2 diabetes. PILA PHARMA AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators